Key Market Indicators
**Dutch Vaccination Coverage Set to Slightly Decline by 2028** The vaccination coverage for Dutch children aged one year old is expected to reach 92 percent by 2028, down from the current 93 percent in 2023. This marks a modest 0.2 percentage point annual decrease. Since 2005, the vaccination rate in the Netherlands has shown little fluctuation. **Stable Vaccination Coverage Over Decades** Examining a longer timeline, since 1985, the Dutch vaccination market has remained stable, maintaining consistent coverage rates over the years. **Significant Drop in Vaccine Imports** In 2023, the value of vaccine imports to the Netherlands plummeted to approximately $31 million, a sharp decline from nearly $56 million in 2022. This 44.9 percent drop reflects a broader trend, with Dutch demand for vaccines decreasing by 26.8 percent annually since 1997. **Modest Growth in Vaccine Exports** On the export front, Dutch vaccine exports are projected to reach roughly $424 million by 2028, up from $412 million in 2023. This represents a slight annual growth rate of 0.3 percent. Since 1997, Dutch vaccine supply has increased by 2.3 percent annually. **Global Vaccine Export Rankings** In 2023, the Netherlands ranked 11th in global vaccine exports, with Canada surpassing it at the same export value of $412 million. Leading the rankings were Belgium, the United Kingdom, and France, occupying the second, third, and fourth positions respectively.
